Medical Device News Magazine

Donald L Deyo Appointed Chairman and Head of US Operations at LindaCare

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

LindaCare is pleased to announce the appointment of Donald L Deyo into the new roles of Executive Chairman of the LindaCare NV and President and CEO of the US subsidiary, LindaCare Inc.  Deyo served as Chairman of the Board for the Company since 2017.

LindaCare is a digital health company specializing in integrated remote cardiac monitoring solutions.  With operations in Europe and USA, the Company facilitates better outcomes for healthcare providers and cardiac rhythm patients with software tools and services essential for their management of these chronically ill patients. The Company provides Software-as-a-Service (SaaS) and Monitoring-as-a-Service (Maas) solutions to meet the needs of health systems, hospitals and private practices throughout the markets in which they operate.

Donald L Deyo is a medtech veteran with extensive experience in development and commercialization of cardiac disease therapies. In the new roles he will guide acceleration of growth in the US and strategic expansion into areas adjacent to and leveraging the Company’s flagship OnePulse™ remote monitoring platform. A former Medtronic executive, Deyo served in various executive roles in Cardiac Rhythm Management (CRM) and Neuromodulation over an extended (29 year) career.

In addition to LindaCare, Deyo currently serves on the board of Nyxoah S.A.  He was a board member for Sapiens Steering Brain Stimulation B.V. prior to acquisition of the company by Medtronic in 2014.  Following Medtronic, Deyo served as President, CEO and board member of FemPulse, Inc and President, CEO and board member of Medallion Therapeutics, both clinical-stage companies developing overactive bladder and targeted drug delivery therapies, respectively.  Deyo also founded the executive consultancy MedTech Execs, which provides strategic and operational services to medical device and pharmaceutical companies.

Commenting on the appointment, Deyo added “I have enjoyed working with the Board and our Founder and CEO, Shahram Sharif, in building our company to this point and am honored to have the opportunity to take on an expanded role in leading the company to its next level of success.”  Sharif added, “Don has been a great partner and mentor for me.  I am looking forward to our expanded partnership and building on our vision for the tremendous potential that is LindaCare.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”